Unions blame ‘greed’ by healthcare providers, state officials say pricey weight-loss meds and increasing demand for care are ...

The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and Zepbound — the brand name of tirzepatide, threatening a workaround that allowed ...

The first time round, 59-year-old James Brown lost a stone and a half when he took medication that aids weight loss. This ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

Now, drinkers are motioning for a cocktail reformation — specifically, smaller aperitifs suitable for shrinking stomachs and the health-conscious in the post-Ozempic world. “There was a ...

Despite its popularity, Ozempic often leads to temporary weight loss, carries serious side effects, and most users regain ...

Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...

GoodRx ran a 12-month survey to better understand the dynamics that shape prescription medication fills and consumer behavior ...